Peng Hou
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 30
- Cancer-related gene regulation 21
- RNA modifications and cancer 20
-
- Thyroid Cancer Diagnosis and Treatment 25
- Co-authors
- Meiju Ji (89 shared papers)Mingzhao Xing (15 shared papers)Qi Yang (44 shared papers)Yiping Qu (25 shared papers)Bingyin Shi (41 shared papers)Haixia Guan (19 shared papers)Dingxie Liu (8 shared papers)Siwen Dang (7 shared papers)
- Journals
- The Journal of Clinical Endocrinology & Metabolism (11 papers)Oncotarget (8 papers)Cell Death and Disease (7 papers)International Journal of Biological Sciences (5 papers)BMC Cancer (5 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Peng Hou
169 papers receiving 5.6k citations
Peers
Comparison fields: 5 of 123
- Endocrinology, Diabetes and Metabolism 1.5k
- Cancer Research 908
- Oncology 1.0k
- Molecular Biology 2.7k
- Pathology and Forensic Medicine 394
Countries citing papers authored by Peng Hou
This map shows the geographic impact of Peng Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Hou more than expected).
Fields of papers citing papers by Peng Hou
This network shows the impact of papers produced by Peng Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Hou. The network helps show where Peng Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Peng Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 314 | |
| 2 | 2008 | 308 | |
| 3 | 2013 | 307 | |
| 4 | 2015 | 185 | |
| 5 | 2009 | 181 | |
| 6 | 2019 | 175 | |
| 7 | 2007 | 156 | |
| 8 | 2019 | 144 | |
| 9 | 2007 | 132 | |
| 10 | 2012 | 120 | |
| 11 | 2009 | 113 | |
| 12 | 2008 | 109 | |
| 13 | 2011 | 78 | |
| 14 | 2019 | 77 | |
| 15 | 2009 | 76 | |
| 16 | 2012 | 72 | |
| 17 | 2011 | 69 | |
| 18 | 2015 | 65 | |
| 19 | 2015 | 62 | |
| 20 | 2020 | 60 |
About Peng Hou
Peng Hou is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Oncology, Cancer Research and Immunology, having authored 175 papers that have together received 5.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (30 papers), Thyroid Cancer Diagnosis and Treatment (25 papers), Cancer-related gene regulation (21 papers), RNA modifications and cancer (20 papers), Cancer-related Molecular Pathways (12 papers), Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (9 papers) and Glioma Diagnosis and Treatment (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.5k citations), Cancer Research (908 citations), Oncology (1.0k citations), Molecular Biology (2.7k citations) and Pathology and Forensic Medicine (394 citations). Peng Hou has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Meiju Ji, Mingzhao Xing, Qi Yang, Yiping Qu, Bingyin Shi, Haixia Guan, Dingxie Liu, Siwen Dang, Fang Sui and Adel K. El‐Naggar. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Oncotarget, Cell Death and Disease, International Journal of Biological Sciences and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.